Effects of Recombinant Erythropoietin in Palliative Treatment of Unselected Cancer Patients

This publication has 36 references indexed in Scilit:

• Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function
  Cancer, 2004
• Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity
  Oncogene, 2003
• Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
  The Lancet, 2003
• Erythropoietin as a critical component of breast cancer therapy: survival, synergistic, and cognitive applications
  Seminars in Oncology, 2003
• Guidelines for the Use of Epoetin: Have Quality-of-Life Benefits Been Proven?
  Journal of Clinical Oncology, 2003
• Human recombinant erythropoietin and quality of life: a wonder drug or something to wonder about?
  The Lancet Oncology, 2002
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI Journal of the National Cancer Institute, 1993
• The effect on body composition and exercise performance of home parenteral nutrition when given as adjunct to chemotherapy of testicular carcinoma
  European Journal of Clinical Investigation, 1991
• Elevated energy expenditure in cancer patients with solid tumours
  European Journal of Cancer and Clinical Oncology, 1991
• Increased Urinary Excretion of Cortisol and Catecholami-NES in Malnourished Cancer Patients
  Annals of Surgery, 1988